Roche's hold on Avastin, Herceptin sales loosens as FDA panel backs Amgen and Mylan biosims
admin 13th July 2017 Uncategorised 0Roche took a blockbuster double hit Thursday as the FDA’s Oncologic Drugs Advisory Committee recommended an Amgen biosimilar to Avastin in the morning, and then a Mylan biosim to Herceptin in the afternoon.
More: Roche's hold on Avastin, Herceptin sales loosens as FDA panel backs Amgen and Mylan biosims
Source: fierce